Free Trial

Zentalis Pharmaceuticals (ZNTL) Insider Trading & Ownership

$3.68
-0.07 (-1.87%)
(As of 09/30/2024 ET)

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.10%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$219,410.00
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$514,324.02
Get ZNTL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zentalis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ZNTL Insider Buying and Selling by Quarter

Zentalis Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2024Cam GallagherCFOSell9,597$11.98$114,972.06  
5/9/2024Diana HausmanInsiderSell3,356$12.62$42,352.72  
2/12/2024Cam GallagherPresidentSell1,173$11.44$13,419.12  
2/12/2024Melissa B EpperlyCFOSell2,573$11.44$29,435.12  
11/13/2023Kimberly BlackwellCEOBuy5,000$10.29$51,450.00  
11/10/2023David Michael JohnsonDirectorBuy17,000$9.88$167,960.00  
10/4/2023Carrie BrownsteinInsiderSell10,628$19.50$207,246.00  
10/4/2023Melissa B EpperlyCFOSell5,482$19.50$106,899.00  
(Data available from 1/1/2013 forward)

ZNTL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Zentalis Pharmaceuticals includes Alexis Pinto, Anthony Y Sun, Cam Gallagher, Carrie Brownstein, David Michael Johnson, Diana Hausman, Dimitris Voliotis, Jan Skvarka, Kevin D Bunker, Kimberly Blackwell, Matrix Capital Management Comp, and Melissa B Epperly. Learn more on insiders at ZNTL.

6.10% of Zentalis Pharmaceuticals stock is owned by insiders. Learn more on ZNTL's insider holdings.

The following insiders have purchased ZNTL shares in the last 24 months: David Michael Johnson ($167,960.00), Kimberly Blackwell ($51,450.00), and Matrix Capital Management Comp ($107,861,600.00).

Insiders have purchased a total of 4,782,000 ZNTL shares in the last 24 months for a total of $108,081,010.00 bought.

The following insiders have sold ZNTL shares in the last 24 months: Cam Gallagher ($2,753,670.98), Carrie Brownstein ($207,246.00), Diana Hausman ($42,352.72), Jan Skvarka ($125,250.00), Kevin D Bunker ($2,479,338.94), and Melissa B Epperly ($189,916.20).

Insiders have sold a total of 235,340 Zentalis Pharmaceuticals shares in the last 24 months for a total of $5,797,774.84 sold.



This page (NASDAQ:ZNTL) was last updated on 10/1/2024 by MarketBeat.com Staff
From Our Partners